EFM
BPMC
E Fund Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $867K | Sell |
6,761
-2,521
| -27% | -$323K | 0.04% | 183 |
|
|
2025
Q1 | $822K | Buy |
9,282
+2,964
| +47% | +$262K | 0.04% | 185 |
|
|
2024
Q4 | $551K | Sell |
6,318
-1,190
| -16% | -$104K | 0.03% | 215 |
|
|
2024
Q3 | $694K | Buy |
7,508
+1,740
| +30% | +$161K | 0.04% | 168 |
|
|
2024
Q2 | $622K | Buy |
5,768
+1,073
| +23% | +$116K | 0.03% | 157 |
|
|
2024
Q1 | $445K | Sell |
4,695
-1,798
| -28% | -$171K | 0.03% | 177 |
|
|
2023
Q4 | $599K | Sell |
6,493
-2,072
| -24% | -$191K | 0.04% | 126 |
|
|
2023
Q3 | $430K | Buy |
8,565
+926
| +12% | +$46.5K | 0.03% | 151 |
|
|
2023
Q2 | $483K | Sell |
7,639
-1,556
| -17% | -$98.4K | 0.04% | 116 |
|
|
2023
Q1 | $414K | Buy |
9,195
+267
| +3% | +$12K | 0.03% | 154 |
|
|
2022
Q4 | $391K | Buy |
8,928
+2,666
| +43% | +$117K | 0.03% | 187 |
|
|
2022
Q3 | $413K | Sell |
6,262
-2,847
| -31% | -$188K | 0.04% | 174 |
|
|
2022
Q2 | $460K | Buy |
9,109
+4,411
| +94% | +$223K | 0.04% | 159 |
|
|
2022
Q1 | $300K | Buy |
+4,698
| New | +$300K | 0.01% | 193 |
|